# Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness

> **NCT03270787** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 58 (actual)

## Conditions studied

- Acute Mountain Sickness

## Interventions

- **DRUG:** Placebo
- **DRUG:** Compound danshen dripping pills

## Key facts

- **NCT ID:** NCT03270787
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-24
- **Primary completion:** 2016-07-13
- **Final completion:** 2017-07-13
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03270787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03270787, "Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03270787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*